Observed Signal · Sep 14, 2026 · Market Signal · Source: Medtronic · Impact: 4.5/5
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
Medtronic shareholders can exchange their Medtronic ordinary shares for shares of MiniMed. Provides Medtronic shareholders with option for a generally tax-free exchange for U.S. federal income tax...
Track Medtronic Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.
Medtronic plc (Medtronic; NYSE: MDT) today announced the final exchange ratio for its previously announced offer to exchange outstanding Medtronic ordinary shares for shares of common stock of MiniMed Group, Inc.
8-K Financial Filing Analysis for Medtronic (2026-09-17)
On September 17, 2026, Medtronic plc filed a Form 8-K to correct a procedural disclosure error regarding its ongoing exchange offer initiated on September 14, 2026. The transaction involves offering up to 225,361,295 newly issued shares of MiniMed Group, Inc. common stock in exchange for outstanding Medtronic ordinary shares, facilitating the separation of MiniMed Group. The filing amends the guaranteed delivery deadline in the prospectus: executed notices of guaranteed delivery expire at 5:00 p.m. NYC time on the second NYSE trading day following execution, correcting a previous typographical error that stated 12:00 midnight.
Medtronic announces cash dividend for second quarter of fiscal year 2027
The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 20, 2026, approved the company's cash dividend for the second quarter of fiscal year 2027 of $0.72 per ordinary share. This...
Receive all future signals for Medtronic & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.